Altering the Proclivity towards Daptomycin Resistance in Methicillin-Resistant Staphylococcus aureus Using Combinations with Other Antibiotics

Adjunctive Rifampin Is Crucial to Optimizing Daptomycin Efficacy against Rabbit Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus

(2011) Azzam Saleh-Mghir et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Striking “Seesaw Effect” between Daptomycin Nonsusceptibility and β-Lactam Susceptibility in Staphylococcus haemolyticus

(2011) Carla Vignaroli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mutation of RNA Polymerase β Subunit (rpoB) Promotes hVISA-to-VISA Phenotypic Conversion of Strain Mu3

(2011) Miki Matsuo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin, Fosfomycin, or Both for Treatment of Methicillin-Resistant Staphylococcus aureus Osteomyelitis in an Experimental Rat Model

(2011) W. Poeppl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates

(2011) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-dose daptomycin and fosfomycin treatment of a patient with endocarditis caused by daptomycin-nonsusceptible Staphylococcus aureus: Case report

(2011) Liang-Yu Chen et al.   BMC INFECTIOUS DISEASES

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia

(2011) Theodoros Kelesidis et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005–2010)

(2011) Helio S. Sader et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus

(2011) Diixa Patel et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach

(2011) Adrien Fischer et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure

(2011) Peter G. Kelley et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Successful Treatment of Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus Aureus Bacteremia with the Addition of Rifampin to Daptomycin

(2010) Nasir M Ahmad et al.   ANNALS OF PHARMACOTHERAPY

Activities of High-Dose Daptomycin, Vancomycin, and Moxifloxacin Alone or in Combination with Clarithromycin or Rifampin in a Novel In Vitro Model of Staphylococcus aureus Biofilm

(2010) J. Parra-Ruiz et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations

(2010) M. E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureus

(2010) C. Garrigos et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides

(2010) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin

(2010) José M. Entenza et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis

(2010) M. Lefebvre et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections

(2010) F. Traunmuller et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus

(2010) W. E. Rose et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Presence of Adequate Intravitreal Concentrations of Daptomycin After Systemic Intravenous Administration in a Patient with Endogenous Endophthalmitis

(2010) Kathleen R Sheridan et al.   PHARMACOTHERAPY

Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus

(2009) N. N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies

(2009) J. N. Steenbergen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Enhanced Expression ofdltABCDIs Associated with the Development of Daptomycin Nonsusceptibility in a Clinical Endocarditis Isolate ofStaphylococcus aureus

(2009) Soo‐Jin Yang et al.   JOURNAL OF INFECTIOUS DISEASES

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions

(2009) Pamela A Moise et al.   LANCET INFECTIOUS DISEASES